Skip to main content

Day: September 17, 2025

Fluence Named a Tier 1 Energy Storage Supplier in S&P Global Commodity Insights’ Premier List of Tier 1 Cleantech Companies 2025

Written by Customer Service on . Posted in Public Companies.

Annual roster reflects top-tier suppliers across energy storage, solar, and wind ARLINGTON, Va., Sept. 17, 2025 (GLOBE NEWSWIRE) — Fluence Energy, Inc. (“Fluence”) (NASDAQ: FLNC), a global market leader delivering intelligent energy storage systems, services, and asset optimization software, today announced that it has been named a Tier 1 energy storage supplier in the inaugural S&P Global Commodity Insights Premier List of Tier 1 Cleantech Companies.   The annual list recognizes leading suppliers across four technology categories: solar PV modules, solar PV inverters, energy storage systems, and wind turbines. Companies are evaluated using a rigorous six-point methodology that considers market presence, manufacturing scale and diversification, financial performance, sustainability factors, and other key indicators....

Continue reading

Live Ventures Announces Successful Turnaround of its Subsidiary Flooring Liquidators

Written by Customer Service on . Posted in Public Companies.

Company Announces Four Consecutive Months of Positive EBITDALAS VEGAS, Sept. 17, 2025 (GLOBE NEWSWIRE) — Live Ventures Incorporated (Nasdaq: LIVE), a diversified holding company with a focus on value-oriented acquisitions of domestic, middle-market companies, today announced the performance turnaround of its wholly-owned subsidiary, Flooring Liquidators Inc. Flooring Liquidators is a leading 30-store retailer and installer of floors, carpets, and countertops; it was acquired by Live Ventures in fiscal year 2023. Jon Isaac, President and Chief Executive of Live Ventures, attributed the turnaround to Flooring Liquidators’ CEO Chris Nichols and the new leadership team Nichols has built. “When Chris took the reins a few months ago, Flooring Liquidators had experienced 24 consecutive months of losses, decreasing margins, and a gradual...

Continue reading

SEGG Media Appoints Concert Industry Veteran Simon Lewis to Concerts.com and TicketStub.com Leadership Team

Written by Customer Service on . Posted in Public Companies.

Industry Momentum Builds as SEGG Media Expands Leadership Amid StubHub IPO Buzz FORT WORTH, Texas, Sept. 17, 2025 (GLOBE NEWSWIRE) — SEGG Media Corporation (NASDAQ: SEGG, LTRYW) (the “Company” or “SEGG Media”), a global sports, entertainment, and gaming group, today announced the appointment of renowned music and concert executive and former President of Live Nation Europe Simon Lewis to a full-time senior consultancy role overseeing the strategic development and commercial rollout of Concerts.com and TicketStub.com. This appointment follows SEGG Media’s recently completed $10 million acquisition of the Concerts.com and TicketStub.com platforms. Simon Lewis is best known for his tenure as President of Live Nation Europe where he helped shape the modern live entertainment landscape through high-impact commercial and brand partnerships...

Continue reading

HomesToLife Ltd Delivers 87% Increase in 1H 2025 Net Income to US$10.0 Million

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Export growth and geographical expansion drive strong first-half performance SINGAPORE, Sept. 17, 2025 (GLOBE NEWSWIRE) — HomesToLife Ltd (Nasdaq: HTLM) (“HomesToLife” or the “Company”), a Singapore-based home furniture company with sales across Asia-Pacific, Europe and North America, today announced its unaudited financial results for the six months ended June 30, 2025 (“1H 2025”). “Strong export sales and favourable foreign exchange gains underpinned a 87% increase in net income to $10.0 million,” said Ms. Phua Mei Ming, Chief Executive Officer of HomesToLife. “Our capital-efficient model delivered a strong 61%1 return on equity in 1H 2025, underscoring the benefits of consolidating all trading and marketing under one group and positioning us for sustained growth in our core B2B furniture business across key international markets.” “While...

Continue reading

Liven AS – acquisition of a new development property in Tallinn, Lasnamäe district

Written by Customer Service on . Posted in Public Companies.

Liven Kodu 23 OÜ, part of the Liven AS consolidation group (Liven), won the auction organised by the Land and Spatial Development Board (Maa- ja Ruumiamet) in September 2025 for the acquisition of a development property located at Linnamäe tee 21a in Tallinn, Lasnamäe district, Kuristiku sub-district. Although the exact construction volume will be determined during the detailed spatial planning process, we are planning a complete residential and commercial building complex on the nearly 8,700 m2 property, which will create contemporary opportunities for living, working and leisure in the area. According to Andres Aavik, Chairman of the Supervisory Board of Liven AS, launching a new development project in Lasnamäe is a step that meets market expectations. “We are very pleased to return to Lasnamäe and to supplement Liven’s development...

Continue reading

Propanc Biopharma Receives Certificate of Grant for “Proenzyme Composition” Patent from US Patent & Trademark Office

Written by Customer Service on . Posted in Public Companies.

Fourth US Granted Patent Captures Claims for Future Clinical Dose of PRP MELBOURNE, Australia, Sept. 17, 2025 (GLOBE NEWSWIRE) — Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that a certificate of grant for the Company’s “proenzyme composition” patent was received from the US Patent & Trademark Office (USPTO). The patent specifically captures a future clinical dose of the Company’s lead asset, PRP. This is the fourth US patent granted in this key strategic jurisdiction. Currently, the Company’s intellectual property portfolio consists of 90 patents filed in major jurisdictions relating to the use of PRP against solid tumors. The proenzymes composition patent is an...

Continue reading

Akari Therapeutics Announces Filing for New Patent for Novel ADC Platform Utilizing Spliceosome Payload PH1 for the Treatment of Cancer

Written by Customer Service on . Posted in Public Companies.

BOSTON and LONDON, Sept. 17, 2025 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced that it has filed a provisional patent application with the United States Patent and Trademark Office (USPTO) covering the Company’s antibody drug conjugate (ADC) platform using Akari’s spliceosome payload PH1 for treating cancer by modulating alternative splicing within cancer cells. This patent application represents a new patent family to further extend Akari’s proprietary position with respect to the Company’s novel payload, PH1 (a novel Thailanstatin analog). Abizer Gaslightwala, President and Chief Executive Officer of Akari Therapeutics commented, “These novel data included in our provisional patent application continue to...

Continue reading

Cingulate Secures Exclusive Manufacturing Partnership with Bend Bio Sciences to Support Future Commercialization of Next Generation ADHD Treatment

Written by Customer Service on . Posted in Public Companies.

Strategic Commercial Supply Agreement Positions Lead Asset CTx-1301 for Launch Pending FDA Approval KANSAS CITY, Kan., Sept. 17, 2025 (GLOBE NEWSWIRE) — Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced it has entered into a commercial supply agreement with Bend Bio Sciences for the manufacturing of CTx-1301(dexmethylphenidate HCl), the company’s lead asset for the treatment of attention deficit/hyperactivity disorder (ADHD). CTx-1301 is a novel, extended-release tablet formulation of dexmethylphenidate designed to address major limitations of current ADHD therapies. Cingulate submitted its NDA to the FDA for CTx-1301 on July...

Continue reading

PolyPid to Present at Lytham Partners Fall 2025 Investor Conference and Participate in 4th Annual ROTH Healthcare Opportunities Conference

Written by Customer Service on . Posted in Public Companies.

PETACH TIKVA, Israel, Sept. 17, 2025 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that management will be presenting at the Lytham Partners Fall 2025 Virtual Investor Conference on September 30, 2025. Additionally, management will be participating in the upcoming 4th Annual ROTH Healthcare Opportunities Conference on October 9, 2025. Lytham Partners Fall 2025 Investor Conference, September 30, 2025, Virtual Management will present at the conference, as part of a fireside chat with Craig-Hallum Senior Research Analyst, Chase Knickerbocker at 4:15 p.m. ET. Management will also be available for one-on-one virtual meetings.Webcast Access: The webcast presentation can be accessed by visiting the...

Continue reading

Digital Utilities Ventures Provides Corporate Update

Written by Customer Service on . Posted in Public Companies.

International contracts, pending FINRA approvals, and OTCQB uplisting efforts position DUTV for expanded revenues and improved market visibility MANKATO, Minn., Sept. 17, 2025 (GLOBE NEWSWIRE) — Digital Utilities Ventures, Inc. (OTC: DUTV), soon to be operating as Easy Environmental Solutions, today issued a corporate update highlighting recent developments across acquisitions, international expansion, and capital markets initiatives. The Company is in the process of acquiring Lifestyle Dock Company and only awaits FINRA approval to complete the acquisition. Lifestyle is a premium manufacturer of luxury docks with a strong distribution network and an East Coast manufacturing facility. Since the Lifestyle acquisition has not been completed, revenues from Lifestyle were not included in DUTV’s recently filed annual report for the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.